|
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by
delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.
Considerations:
- Revenue-generating biosciences company focused on improving the delivery of bioactive compounds through gourmet foods
- Proprietary technology shown to enhance the bioavailability of orally ingested cannabinoids while improving the taste
- Actively developing and selling hemp oil-based gourmet food products through consumer brands ViPova™ and Lexaria Energy
- Partnership with one of the world’s largest cigarette companies provides up to US$12 million in funding for clinical investigations conducted by Lexaria Nicotine LLC to explore oral forms of nicotine delivery using the Company’s patented DehydraTECH™ technology
|
